Evaluate SLS stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in SLS? | Glauxie AI

Q: What are the risks of investing in SLS?

SELLAS Life Sciences Group, Inc. (SLS) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Angelos Stergiou. SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead... Employees: 13.

Q: How much debt does SLS have?

Review SLS total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is SLS a good long-term investment?

Evaluate SLS as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in SLS?

🦉

SELLAS Life Sciences Group, Inc. (SLS)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOAngelos Stergiou

SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1,...

Key Executives

Name	Title
Andrew Elnatan	Senior Vice President of Regulatory Affairs, CMC & Quality
Angelos Stergiou	Founder, President, Chief Executive Officer & Director
Dragan Cicic	Senior Vice President & Chief Development Officer
John Thomas Burns	Senior Vice President & Chief Financial Officer
Stacy Yeung	VP, General Counsel & Corporate Secretary

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

SLS Profile Financials

Is SLS stock safe? How much debt does SLS have? Is SLS a good long-term investment?